New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S2757

Introduced
2/15/24  

Caption

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Impact

The enactment of S2757 would significantly affect the regulations governing health insurance policies in New Jersey. By mandating that all health benefits plans deliver coverage for continuous glucose monitoring systems, the bill aims to eliminate disparities in care for patients suffering from glycogen storage disease. This change signifies a broader effort to make necessary medical technologies accessible, potentially influencing additional legislative measures that focus on chronic condition management and preventive health strategies. Moreover, it emphasizes the importance of personalized medical treatment where monitoring is critical.

Summary

Bill S2757, introduced to the New Jersey Legislature, aims to require health benefit plans to provide coverage for continuous glucose monitoring systems specifically for the treatment of glycogen storage disease. This provision would ensure that expenses incurred from purchasing and using these monitoring systems, when prescribed by healthcare practitioners, are covered under various health plans, including those from hospital, medical service corporations, health maintenance organizations, and state programs. The bill is a significant step towards enhancing the scope of medical benefits provided to individuals affected by this rare metabolic disorder, thereby addressing an essential healthcare need.

Contention

Despite its potential benefits, the bill may also encounter points of contention during the legislative process. There may be concerns raised by insurance providers regarding the financial implications of mandatory coverage requirements, possibly leading to debates on cost burdens versus patient rights. Additionally, while advocates for patients and healthcare equity may support S2757, opponents could argue about the scope of mandated coverage and the precedent it sets for health insurers. Balancing these viewpoints will be crucial to the bill’s progression through legislative discussions.

Companion Bills

NJ A4628

Same As Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

NJ A3768

Carry Over Requires health benefits coverage of continuous glucose monitoring systems for treatment of glycogen storage disease.

NJ S3815

Carry Over Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Previously Filed As

NJ A3768

Requires health benefits coverage of continuous glucose monitoring systems for treatment of glycogen storage disease.

NJ S3815

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

NJ A4628

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

NJ HB758

Require insurance coverage of continuous glucose monitoring supplies

NJ A4781

Requires health insurance coverage for certain obesity treatments.

NJ S3259

Requires health insurance coverage for certain obesity treatments.

NJ S2448

Requires health insurance coverage for certain obesity treatments.

NJ A5790

Requires health benefits coverage for treatment of lipedema.

NJ S4495

Requires health benefits coverage for treatment of lipedema.

NJ A5325

Requires health insurance coverage for certain neurological diseases.

Similar Bills

NJ A3768

Requires health benefits coverage of continuous glucose monitoring systems for treatment of glycogen storage disease.

NJ A4628

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

NJ S3815

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

CT HB07200

An Act Implementing The Recommendations Of The Task Force On Life-threatening Food Allergies In Schools.

CT HB05452

An Act Concerning The Recommendations Of The Task Force On Life-threatening Food Allergies In Schools.

CT HB05348

An Act Concerning The Administration Of Medicine To Students With Diabetes, The Duties Of School Medical Advisors, The Availability Of Cpr And Aed Training Materials For Boards Of Education And Physical Exercise During The School Day.

LA SB257

Provides relative to Medicaid coverage for continuous glucose monitors. (8/1/22)

AR HB1008

To Modify The Coverage Of Continuous Glucose Monitors In The Arkansas Medicaid Program.